Shopping Cart
- Remove All
- Your shopping cart is currently empty
Odesivimab (REGN-3471) is a human monoclonal antibody targeting the Zaire strain of Ebola virus, with potential antiviral activity, used for research on Ebola virus infection.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $247 | In Stock | |
5 mg | $645 | In Stock | |
10 mg | $987 | In Stock | |
25 mg | $1,530 | In Stock | |
50 mg | $1,980 | In Stock |
Description | Odesivimab (REGN-3471) is a human monoclonal antibody targeting the Zaire strain of Ebola virus, with potential antiviral activity, used for research on Ebola virus infection. |
In vitro | Odesivimab, Atoltivimab and Maftivimab can be combined to form REGN-EB3 with an IC50 value of 0.39 nM, which can be used for Ebola virus research. Odesivimab showed specific binding to soluble viral glycoprotein. [1] |
In vivo | Odesivimab with Atoltivimab and Maftivimab (REGN-3471, 50 mg/kg) were protective against Ebola virus infected rhesus monkey models. [1] |
Alias | REGN-3471, REGN3471 |
Cas No. | 2135632-30-1 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.